Journal of Biological Chemistry
Volume 297, Issue 1, July 2021, 100770
Accelerated CommunicationEditors' PickMolnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
Editors' Pick
Under a Creative Commons license
open access
Keywords
coronavirus
SARS-CoV-2
Covid-19
RNA-dependent RNA polymerase
drug development
antiviral agent
mutagen
nucleoside analogue
Abbreviations
NHC
β-D-N4-hydroxycytidine
NHC-MP
NHC monophosphate
NHC-TP
NHC 5’-triphosphate
RdRp
RNA-dependent RNA polymerase
RDV
remdesivir
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
Cited by (0)
Calvin Gordon is a PhD student in the Department of Medical Microbiology and Immunology at University of Alberta. The focus of Calvin’s research is on broad-spectrum antivirals and their mechanism of action against various RNA viral polymerases. He is currently investigating mutagenic mechanisms of molnupiravir against RNA viruses that possess high epidemic potential.
© 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.